ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
Stockman
|
13 |
1.9K |
4 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
13
|
1.9K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
Stockman
|
13 |
1.9K |
3 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
13
|
1.9K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Orphan drug week - 22nd to 26th April
|
|
Stockman
|
24 |
6.0K |
5 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
24
|
6.0K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Alpha-synuclein induced synucleinopathies and NBIA's
|
|
Stockman
|
10 |
3.0K |
5 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
10
|
3.0K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Parkinson's and MSA Data Featured at AAN Meeting
|
|
Stockman
|
22 |
5.7K |
4 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
22
|
5.7K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Parkinson's and MSA Data Featured at AAN Meeting
|
|
Stockman
|
22 |
5.7K |
5 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
22
|
5.7K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Parkinson's and MSA Data Featured at AAN Meeting
|
|
Stockman
|
22 |
5.7K |
6 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
22
|
5.7K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Parkinson's and MSA Data Featured at AAN Meeting
|
|
Stockman
|
22 |
5.7K |
9 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
22
|
5.7K
|
9
|
|
ASX - By Stock
|
ATH |
Re:
another good day in New York
|
|
Stockman
|
24 |
6.3K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
24
|
6.3K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
another good day in New York
|
|
Stockman
|
24 |
6.3K |
7 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
24
|
6.3K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
another good day in New York
|
|
Stockman
|
24 |
6.3K |
9 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
24
|
6.3K
|
9
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
Stockman
|
113 |
26K |
6 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
113
|
26K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
Stockman
|
113 |
26K |
4 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
113
|
26K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
Stockman
|
113 |
26K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
113
|
26K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
Stockman
|
113 |
26K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
113
|
26K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
AAN conference new data predictions
|
|
Stockman
|
19 |
6.1K |
2 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
19
|
6.1K
|
2
|
|
ASX - By Stock
|
ATH Biotech |
Re:
AAN conference new data predictions
|
|
Stockman
|
19 |
6.1K |
7 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
19
|
6.1K
|
7
|
|
ASX - By Stock
|
CNJ |
Re:
Ann: Placement and Pro-Rata Non-Renounceable Rights Offer
|
|
Stockman
|
60 |
18K |
16 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
60
|
18K
|
16
|
|
ASX - By Stock
|
CNJ |
Re:
Ann: Placement and Pro-Rata Non-Renounceable Rights Offer
|
|
Stockman
|
60 |
18K |
9 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
60
|
18K
|
9
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
Stockman
|
113 |
26K |
4 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
113
|
26K
|
4
|
|
ASX - By Stock
|
CNJ |
Re:
Ann: Placement and Pro-Rata Non-Renounceable Rights Offer
|
|
Stockman
|
60 |
18K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
60
|
18K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
Stockman
|
113 |
26K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
113
|
26K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
Stockman
|
113 |
26K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
113
|
26K
|
0
|
|
ASX - By Stock
|
CNJ |
Re:
Ann: Pro-Rata Non-Renounceable Rights Offer (Correction)
|
|
Stockman
|
30 |
6.8K |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
30
|
6.8K
|
5
|
|
ASX - By Stock
|
CNJ |
Re:
Ann: Pro-Rata Non-Renounceable Rights Offer (Correction)
|
|
Stockman
|
30 |
6.8K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
30
|
6.8K
|
5
|
|
ASX - By Stock
|
CNJ |
Re:
Ann: Pro-Rata Non-Renounceable Rights Offer (Correction)
|
|
Stockman
|
30 |
6.8K |
11 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
30
|
6.8K
|
11
|
|
ASX - By Stock
|
CNJ |
Re:
Ann: Placement and Pro-Rata Non-Renounceable Rights Offer
|
|
Stockman
|
60 |
18K |
6 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
60
|
18K
|
6
|
|
ASX - By Stock
|
CNJ |
Re:
Ann: Placement and Pro-Rata Non-Renounceable Rights Offer
|
|
Stockman
|
60 |
18K |
11 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
60
|
18K
|
11
|
|
ASX - By Stock
|
CNJ |
Re:
Ann: Placement and Pro-Rata Non-Renounceable Rights Offer
|
|
Stockman
|
60 |
18K |
13 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
60
|
18K
|
13
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
Stockman
|
2 |
910 |
10 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
2
|
910
|
10
|
|
ASX - By Stock
|
AGN |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation For HIE
|
|
Stockman
|
18 |
5.1K |
8 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
18
|
5.1K
|
8
|
|
ASX - By Stock
|
ATH |
Re:
The ape study in AAN
|
|
Stockman
|
3 |
934 |
3 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
3
|
934
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
Stockman
|
113 |
26K |
5 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
113
|
26K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
Stockman
|
113 |
26K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
113
|
26K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
Stockman
|
113 |
26K |
4 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
113
|
26K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
Stockman
|
113 |
26K |
5 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
113
|
26K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
Stockman
|
113 |
26K |
3 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
113
|
26K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
Stockman
|
113 |
26K |
5 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
113
|
26K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
Stockman
|
113 |
26K |
3 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
113
|
26K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
Stockman
|
113 |
26K |
6 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
113
|
26K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
Stockman
|
113 |
26K |
8 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
113
|
26K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
News: IMU Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update
|
|
Stockman
|
30 |
18K |
39 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
30
|
18K
|
39
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Stockman
|
13K |
6.3M |
31 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
13K
|
6.3M
|
31
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Notice Under Section 708A
|
|
Stockman
|
48 |
12K |
6 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
48
|
12K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Notice Under Section 708A
|
|
Stockman
|
48 |
12K |
3 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
48
|
12K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Notice Under Section 708A
|
|
Stockman
|
48 |
12K |
2 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
48
|
12K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Notice Under Section 708A
|
|
Stockman
|
48 |
12K |
11 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
48
|
12K
|
11
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Notice Under Section 708A
|
|
Stockman
|
48 |
12K |
7 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
48
|
12K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Notice Under Section 708A
|
|
Stockman
|
48 |
12K |
6 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
48
|
12K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Notice Under Section 708A
|
|
Stockman
|
48 |
12K |
18 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
48
|
12K
|
18
|
|